Hikma Slashes Generics Forecast After Key Product Delay

Expected US Launch Of Authorized Generic Xyrem Slips To As Late As 2023

 
• By David Wallace
  
Cut Dollars Slash Sales Forecast
Hikma has cut its generics sales expectations • Source: Maren Winter / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products